Upper gastrointestinal lesions associated with non-steroidal anti-inflammatory drug (NSAID) 
All bone marrow examinations and most endoscopies were carried out during hospital admission. All endoscopies during the period of the study were performed independently by two operators and reported in the standardised format normally used in the gastroenterology unit. A lesion was defined as a macroscopic breach of mucosa in the oesophagus, stomach, or duodenum. This included lesions such as erosions and ulcers but excluded abnormalities such as erythema or intramucosal haemorrhage, the significance of which is controversial.
A faecal occult blood test had been performed on the subjects as inpatients using the Haemoccult test on three consecutive days. The test was considered positive if any of the three samples were positive. Where endoscopic healing was confirmed the haemoglobin concentration was followed up for at least three months after healing. An improvement of anaemia in these patients was defined as a sustained rise in haemoglobin >15 g/l.
Results Table 1 A previous study'0 has also reported a similar prevalence of upper gastrointestinal lesions. All patients with anaemia were included, however, irrespective of the type. In addition, lesions of the oesophagus were excluded. The association of oesophageal lesions with NSAID treatment is recognised" 12 and may be an important cause of anaemia in such patients. Two of the four patients with oesophageal ulceration in our study had episodes of haematemesis related to the lesion. There was only a small number of smokers (14 of 104) among our patients. It has been noted that the rate at which smoking is stopped rises with age, ' which may explain the small number of smokers in our group. Alternatively, this may be related to their chronic disease and the repeated instructions to stop smoking, during their clinic attendance. Smoking was not associated with either dyspepsia or upper gastrointestinal lesions in our patients. The study also confirms that upper gastrointestinal lesions may be satisfactorily healed with H2 antagonist treatment despite continuing NSAID treatment.14 '5 Interestingly, five of the nine patients who were taking H2 antagonists as maintenance treatment following previous peptic ulcer disease had upper gastrointestinal lesions. All these patients were free from dyspeptic symptoms. This clearly shows the problem of asymptomatic recurrence of peptic ulcer disease while they were receiving maintenance H2 antagonist treatment.
Barium enema examination was not helpful in identifying the source of blood loss. Patients with significant ileocolonic inflammation may have normal barium enema. Alternatively, the significance of diverticulosis as the cause for anaemia can be debated. In our study the two patients with filling defects on barium enema turned out to be false positives. It No correlation between the presence of dyspepsia and upper gastrointestinal lesions could be shown in this study. Although this correlation is well known in patients receiving NSAIDs,5 6 it has not been reported in patients with iron deficiency before. In such a group of patients, therefore, the presence or absence of dyspepsia should not decide the plan of investigation.
Our study also confirms the previously reported poor correlation between a positive faecal occult blood test and upper gastrointestinal lesions.'9 It also shows that only a small number of our patients were positive for this test, probably because the Haemoccult card test was used, which is insensitive to blood loss caused by NSAIDs. 20 In conclusion, our study indicates that upper gastrointestinal lesions have been overestimated as the cause of iron deficiency anaemia in patients receiving NSAIDs. Perhaps intestinal blood loss may be a more important cause of anaemia in such patients.
